irAEs — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Withhold nivolumab and establish glucocorticoid replacement before introducing levothyroxine
The pattern indicates hypophysitis with secondary adrenal insufficiency and central hypothyroidism. Cortisol replacement must precede levothyroxine to avoid precipitating adrenal crisis. OPDIVO should be withheld for symptomatic grade 2/3 hypophysitis until stabilisation; endocrine toxicity is generally managed with replacement rather than automatic permanent discontinuation.
Reference: OPDIVO UK summary of product characteristics (Current UK SmPC, accessed August 2026): https://www.medicines.org.uk/emc/product/6888/smpc